BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21637737)

  • 1. Estimating Causal Effects in Trials Involving Multi-Treatment Arms Subject to Non-compliance: A Bayesian framework.
    Long Q; Little RJ; Lin X
    J R Stat Soc Ser C Appl Stat; 2010 May; 59(3):513-531. PubMed ID: 21637737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An extended general location model for causal inferences from data subject to noncompliance and missing values.
    Peng Y; Little RJ; Raghunathan TE
    Biometrics; 2004 Sep; 60(3):598-607. PubMed ID: 15339281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of estimands in clinical trials with imperfect compliance.
    Chen H; Heitjan DF
    Int J Biostat; 2024 May; 20(1):57-67. PubMed ID: 37365674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the sensitivity of methods for estimating principal causal effects.
    Stuart EA; Jo B
    Stat Methods Med Res; 2015 Dec; 24(6):657-74. PubMed ID: 21971481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing complier average causal effects from longitudinal trials with multiple endpoints and treatment noncompliance: An application to a study of Arthritis Health Journal.
    Guo L; Qian Y; Xie H
    Stat Med; 2022 Jun; 41(13):2448-2465. PubMed ID: 35274333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarifying selection bias in cluster randomized trials.
    Li F; Tian Z; Bobb J; Papadogeorgou G; Li F
    Clin Trials; 2022 Feb; 19(1):33-41. PubMed ID: 34894795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bayesian hierarchical model estimating CACE in meta-analysis of randomized clinical trials with noncompliance.
    Zhou J; Hodges JS; Suri MFK; Chu H
    Biometrics; 2019 Sep; 75(3):978-987. PubMed ID: 30690716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of treatment efficacy with complier average causal effects (CACE) in a randomized stepped wedge trial.
    Gruber JS; Arnold BF; Reygadas F; Hubbard AE; Colford JM
    Am J Epidemiol; 2014 May; 179(9):1134-42. PubMed ID: 24705812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Complier Average Causal Effect Parameter for Multiarmed RCTs.
    Schochet PZ
    Eval Rev; 2020 Oct; 44(5-6):410-436. PubMed ID: 33375826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian phase II clinical trial design with noncompliance.
    Ren T; Shen W; Zhang L; Zhao H
    Stat Med; 2021 Sep; 40(20):4457-4472. PubMed ID: 34050539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Handling missing data in randomized experiments with noncompliance.
    Jo B; Ginexi EM; Ialongo NS
    Prev Sci; 2010 Dec; 11(4):384-96. PubMed ID: 20379779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating causal effects of treatment in RCTs with provider and subject noncompliance.
    Sheng E; Li W; Zhou XH
    Stat Med; 2019 Feb; 38(5):738-750. PubMed ID: 30347462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE POTENTIAL FOR BIAS IN PRINCIPAL CAUSAL EFFECT ESTIMATION WHEN TREATMENT RECEIVED DEPENDS ON A KEY COVARIATE.
    Zigler CM; Belin TR
    Ann Appl Stat; 2011; 5(3):1876-1892. PubMed ID: 22308190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple Estimation of Patient-Oriented Effects From Randomized Trials: An Open and Shut CACE.
    Steele RJ; Shrier I; Kaufman JS; Platt RW
    Am J Epidemiol; 2015 Sep; 182(6):557-66. PubMed ID: 26283090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the Complier Average Causal Effect in a Meta-Analysis of Randomized Clinical Trials With Binary Outcomes Accounting for Noncompliance: A Generalized Linear Latent and Mixed Model Approach.
    Zhou T; Zhou J; Hodges JS; Lin L; Chen Y; Cole SR; Chu H
    Am J Epidemiol; 2022 Jan; 191(1):220-229. PubMed ID: 34564720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating causal effects of internet interventions in the context of nonadherence.
    Hesser H
    Internet Interv; 2020 Sep; 21():100346. PubMed ID: 32983907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond intent to treat (ITT): A complier average causal effect (CACE) estimation primer.
    Peugh JL; Strotman D; McGrady M; Rausch J; Kashikar-Zuck S
    J Sch Psychol; 2017 Feb; 60():7-24. PubMed ID: 28164801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model misspecification sensitivity analysis in estimating causal effects of interventions with non-compliance.
    Jo B
    Stat Med; 2002 Nov; 21(21):3161-81. PubMed ID: 12375297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An introduction to causal modeling in clinical trials.
    Bellamy SL; Lin JY; Ten Have TR
    Clin Trials; 2007; 4(1):58-73. PubMed ID: 17327246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bayesian approach to estimating causal vaccine effects on binary post-infection outcomes.
    Zhou J; Chu H; Hudgens MG; Halloran ME
    Stat Med; 2016 Jan; 35(1):53-64. PubMed ID: 26194767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.